S. Meade

发表

RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic

G. Perkins, L. Forni, M. Wise, 2021, Thorax.

The effects of COVID‐19 on IBD prescribing and service provision in a UK tertiary centre

J. Sanderson, M. Samaan, P. Pavlidis, 2020, GastroHep.

Contemporary Management of Cardiogenic Shock: A RAND Appropriateness Panel Approach

H. Thiele, F. Burzotta, D. Morrow, 2021, Circulation. Heart failure.

Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel

C. Lees, A. Hart, C. Lamb, 2020, Gut.

Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel

R. Muhammed, V. Shivamurthy, M. Samaan, 2020, Gut.

Implementation of an intervention bundle leads to quality improvement in ulcerative colitis endoscopy reporting

O. Ahmad, M. Samaan, J. Segal, 2020, GastroHep.

An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch

M. Samaan, S. Anderson, P. Irving, 2021, Alimentary pharmacology & therapeutics.

Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel

M. Samaan, E. Benchimol, R. Hansen, 2022, Journal of Crohn's & colitis.

A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a UK tertiary IBD centre

M. Lomer, M. Samaan, P. Pavlidis, 2022, Alimentary pharmacology & therapeutics.

Observations on the Adherence of Bacteroides Bivius to Female Genital Tract and Oral Epithelial Cells

S. Meade, 1985 .

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Sarah F. Griffee, Susan M. Kilroy, Philip Smith, 2022, The Lancet Gastroenterology & Hepatology.

Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Michael P. Jones, M. Samaan, P. Irving, 2021, Digestive Diseases and Sciences.

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Susan M. Kilroy, C. Lees, T. Ahmad, 2022, Nature Communications.

Emerging Treatments for Crohn's Disease: Cells, Surgery, and Novel Therapeutics

M. Samaan, P. Irving, S. Meade, 2021 .

Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study

M. Samaan, P. Pavlidis, S. Anderson, 2022, JGH open : an open access journal of gastroenterology and hepatology.

How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?

M. Samaan, S. Anderson, P. Irving, 2022, Frontline Gastroenterology.

Positioning intestinal ultrasound in a UK tertiary centre: significant estimated clinical role and cost savings

P. Irving, S. Zeki, K. Gecse, 2022, Frontline Gastroenterology.

Autoimmune haemolytic anaemia is a rare association with primary biliary cirrhosis.

A. Gera, A. Loganayagam, S. Meade, 2016, British journal of hospital medicine.

ECCO Topical Review: Roadmap to optimal peri-operative care in IBD.

S. Sebastian, A. Spinelli, G. Pellino, 2022, Journal of Crohn's & colitis.